Wallace Advisory Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Sell
1,100
-175
-14% -$36.9K 0.22% 120
2025
Q4
$253K Sell
1,275
-1,419
-53% -$287K 0.27% 105
2025
Q3
$474K Buy
2,694
+1,059
+65% +$188K 0.38% 79
2025
Q2
$220K Buy
+1,635
New +$246K 0.16% 162

Other funds holding THC

Wallace Advisory Group's THC Position: Q1 2026 in Review

Wallace Advisory Group reduced its Tenet Healthcare (THC) stake by 14% in Q1 2026, selling an estimated $36.9K and leaving 1,100 shares worth $208K. The position accounts for 0.22% of the portfolio, ranked #120.

Wallace Advisory Group first reported a position in THC in Q2 2025 and has held it in 4 quarters since. The position peaked at $474K in Q3 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Wallace Advisory Group held 1,100 shares of Tenet Healthcare worth $208K as of Q1 2026.
  • Wallace Advisory Group sold 175 Tenet Healthcare shares in Q1 2026, an estimated $36.9K.
  • Tenet Healthcare made up 0.22% of Wallace Advisory Group's portfolio in Q1 2026, its #120 holding.
  • Wallace Advisory Group first reported a position in Tenet Healthcare in Q2 2025 and has held it in 4 quarters since.
  • Wallace Advisory Group's Tenet Healthcare position peaked at $474K in Q3 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Wallace Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.